Manuscript Discussing the Benefit of SeaStar Medical’s Selective Cytopheretic Device in Patients with Heart Failure and Hyperinflammation Published in European Journal of Heart Failure
27 févr. 2024 08h30 HE
|
SeaStar Medical Holding Corporation
Interest continues to grow in developing new strategies to reduce systemic inflammation as a means of improving outcomes in heart failure patients DENVER, Feb. 27, 2024 (GLOBE NEWSWIRE)...
ICU Beds Global Market Report 2024: Strong Growth and Technological Advancements in Healthcare - Long-term Forecasts to 2028 and 2033
26 janv. 2024 04h36 HE
|
Research and Markets
Dublin, Jan. 26, 2024 (GLOBE NEWSWIRE) -- The "ICU Beds Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The recent ICU Beds Global Market Report for 2024...
FDA Issues Approvable Letter for SeaStar Medical’s Selective Cytopheretic Device for Pediatric Patients
30 oct. 2023 08h00 HE
|
SeaStar Medical Holding Corporation
DENVER, Oct. 30, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences of dysregulated...
Rise in Chronic Health Conditions and Telehealth Services Propel Critical Care Diagnostics Market Growth
23 oct. 2023 06h53 HE
|
Research and Markets
Dublin, Oct. 23, 2023 (GLOBE NEWSWIRE) -- The "Critical Care Diagnostics Market Size, Share & Trends Analysis Report By Type (Flow Cytometry, Hematology), By End-use (Operating Room, Emergency...
CytoSorbents to Present at the 8th Annual Dawson James Conference
05 oct. 2023 07h00 HE
|
CytoSorbents
CytoSorbents to Highlight Company Progress at Dawson James Small Cap Investor Growth Conference
Exploring Tele-ICU Market Opportunities: Global Market Expansion from 2023 to 2030
25 sept. 2023 08h43 HE
|
Research and Markets
Dublin, Sept. 25, 2023 (GLOBE NEWSWIRE) -- The "Tele-Intensive Care Unit (ICU) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Tele-Intensive...
CytoSorbents Announces Kathleen P. Bloch To Resume as Full-Time Chief Financial Officer
19 sept. 2023 07h00 HE
|
CytoSorbents
PRINCETON, N.J., Sept. 19, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care therapy leader commercializing its CytoSorb® blood purification technology to treat...
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil
31 août 2023 07h00 HE
|
CytoSorbents
PRINCETON, N.J., Aug. 31, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care therapy leader commercializing its CytoSorb® blood purification technology to treat...
CytoSorbents Appoints Alexander D’Amico as Chief Financial Officer
19 juil. 2023 07h00 HE
|
CytoSorbents
PRINCETON, N.J., July 19, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
SeaStar Medical Provides Regulatory Update Related to its HDE Application for Pediatric Selective Cytopheretic Device
09 mai 2023 16h05 HE
|
SeaStar Medical Holding Corporation
DENVER, May 09, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences of hyperinflammation...